Abivax doses first patient in Phase II/III Covid-19 clinical trial

The randomised, double-blind, placebo-controlled miR-AGE study investigates the effect of early treatment in 1,034 elderly or high-risk Covid-19 patients. Credit: Governor Tom Wolf.